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Glucose-induced fibronectin and collagen type III expression mesangial expansion and proliferation, increased pro-
in renal fibroblasts can occur independent of TGF-1. duction of matrix components, and tubulointerstitial fi-
Background. Various renal cell types have been shown to brosis [1–3]. It is widely accepted that lesions affectingcontribute to the excessive matrix deposition observed in dia-
the glomerulus are responsible for the clinical manifesta-betic nephropathy. The present study examined the effect of
tions of diabetic nephropathy. However, the degree ofhigh ambient glucose and transforming growth factor-1
(TGF-1) on matrix production by human renal fibroblasts. tubulointerstitial fibrosis is also closely correlated with
Methods. Human renal fibroblasts (TK173) were used to the degree of mesangial matrix expansion and decline in
examine the effects of high glucose and TGF-1 on fibronectin glomerular filtration rate [4–6]. Relatively little is knownand collagen type III expression. Stable transfectants were
about the development of tubulointerstitial fibrosis ingenerated of TK173 cells expressing a dominant negative TGF-
type II receptor. Matrix components were measured in enzyme- diabetic nephropathy.
linked immunosorbent assay (ELISA) and reverse transcrip- The histologic characteristics of diabetic nephropathy
tion-polymerase chain reaction (RT-PCR). are caused by excessive deposition of extracellular ma-
Results. Fibronectin secretion by renal fibroblasts was in-
trix (ECM) proteins, which are induced by growth factorscreased upon exposure to high glucose, but with delayed kinet-
and the hyperglycemic milieu [7–9]. Hyperglycemia in vitroics compared to TGF-1-induced fibronectin. Exposure to high
glucose resulted in an increased secretion of latent TGF-1. has been extensively studied in glomerular cells (i.e.,
However, treatment with neutralizing pan-specific anti-TGF- mesangial cells) [10–12]. Numbers of renal fibroblasts
antibodies could not attenuate the effects of glucose. Further- are increased during fibrosis [13], and may play a rolemore, collagen type III was up-regulated by high glucose, but
in the progression of diabetic nephropathy [14]. Rela-not by TGF-1. Importantly, fibroblasts expressing a dominant
negative TGF- type II receptor were defective in TGF-1- tively few studies have investigated the effect of hyper-
induced fibronectin production, whereas glucose-induced fi- glycemic conditions, but an increase in collagen produc-
bronectin and collagen type III were unaffected. tion after exposure to elevated glucose concentrations
Conclusions. These data show that in renal fibroblasts expo-
has been shown in murine and human fibroblasts [15, 16].sure to high glucose can increase matrix production indepen-
Transforming growth factor-1 (TGF-1) is a fibro-dent of endogenous TGF-1. Although glucose activation is
accompanied by an increased production of latent TGF-1, genic cytokine that exerts its effects on cells that are
which can have an important role in vivo, the data suggest related to growth and accumulation of ECM (reviewed
involvement of alternative growth factors in the mechanism in [17]). Previous studies have demonstrated the closeby which hyperglycemic conditions can modulate matrix accu-
resemblance of the effect of TGF-1 and high ambientmulation in diabetic nephropathy.
glucose on the synthesis of ECM components [18]. It
has been suggested that the high glucose-induced accu-
mulation of ECM is mediated by TGF-1, since TGF-1Diabetic nephropathy develops in 30% to 40% of pa-
tients with diabetes mellitus. It is characterized by thick- is up-regulated under high glucose conditions [12, 15,
ening of the glomerular and tubular basement membranes, 19]. Also, the effects of high ambient glucose could be
attenuated by neutralization of the effects of TGF-1
[15, 19]. Moreover, increased expression of TGF-1 wasKey words: diabetic nephropathy, fibrosis, fibroblasts, fibronectin, col-
lagen type III, TGF-1. found in diabetic nephropathy [20, 21]. Furthermore, it
has been demonstrated that treatment of streptozotocin-Received for publication July 11, 2002
induced diabetic mice with a neutralizing anti-TGF-1and in revised form September 13, 2002
Accepted for publication October 22, 2002 monoclonal antibody attenuated kidney hypertrophy
and enhanced ECM gene expression [22]. Therefore, 2003 by the International Society of Nephrology
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it is thought that TGF-1 plays a central role in the Cells were trypsinized and viable cells were counted us-
ing trypan blue exclusion.development of diabetic nephropathy.
It has been suggested that there is a link between the
Fibronectin inhibition ELISApresence of fibroblasts in the kidney and the progression
of diabetic nephropathy [14], and that fibronectin might Fibronectin accumulation in supernatants was mea-
sured using a specific inhibition ELISA. For the detec-be an important determinant of the fibrotic process in
the kidney [23]. In addition, up-regulation of collagen tion of fibronectin, 96-well Nunc Maxisorb microtitre
plates (Gibco/Life Technologies) were coated with 125type III has also been correlated with tubulointerstitial
fibrosis [24, 25]. Therefore, we examined the effects of ng/mL human fibronectin (Sigma) in 50 mmol/L carbon-
ate buffer at pH 9.6 (100 L/well) overnight at roomhigh ambient glucose and TGF-1 on the expression of
fibronectin and collagen type III by human renal fibro- temperature. Fibronectin standard or samples were pre-
incubated overnight at 4C with the same volume of 1:4000blasts. We demonstrated that glucose-induced fibronec-
tin and collagen type III can occur independent of endog- diluted (1:8000 final concentration) goat antihuman fi-
bronectin (Sigma) in phosphate-buffered saline (PBS),enous TGF-1 in a human renal fibroblast cell line.
Although the secretion of latent TGF-1 is also induced 0.05%, Tween, 1%, FCS. After washing the plates with
PBS, 0.05%, Tween, 100 L of the preincubated stan-by glucose, additional growth factors might be involved
in the mechanism by which hyperglycemia can modulate dard or sample was added onto the plates and incubated
at room temperature for 30 minutes. After washing theECM accumulation.
plates, a peroxidase-conjugated secondary rabbit anti-
goat IgG (Nordic Immunology, Tilburg, The Nether-
METHODS
lands) was added and incubated for 1 hour at 37C. The
Cell culture ELISA was developed with 2,2-amino-bis-3-ethylbenz-
thiazoline-6-sulfonic acid (ABTS)/H2O2. SupernatantsSV40-transformed human renal fibroblast cell lines
TK173 (from normal kidney) and TK188 (from fibrotic were measured in various dilutions, and calculated in
the linear part of the curve.kidney) have been previously characterized [26]. The
cells were maintained in Dulbecco’s modified Eagle’s
Collagen type III inhibition ELISAmedium (DMEM), supplemented with 10% heat-inacti-
vated fetal calf serum (FCS), 100 IU/mL penicillin, and Collagen type III accumulation in supernatants was
measured using a specific inhibition ELISA similar to100 g/mL streptomycin (all purchased at Gibco/Life
Technologies, Paisley, Scotland) in 75 cm2 culture flasks fibronectin. Microtiter plates were coated with 0.5g/mL
human collagen type III (Sigma) in PBS (100 L/well)(Greiner, Frickenhausen, Germany) at 37C in a humidi-
fied incubator with 5% carbon dioxide (CO2)/95% air. overnight at room temperature. Collagen type III stan-
dard or samples were preincubated overnight at 4C withFor experimental purposes, cells were trypsinized and
seeded at a density of 50,000 cells/well in 48-well plates the same volume of 1:500 diluted (1:1000 final concentra-
tion) goat antihuman collagen type III (Immunologi-(Costar, Corning, NY) and grown in DMEM containing
10% FCS for 24 hours to reach confluence. Subse- calsDirect, Oxfordshire, UK) in PBS, 0.05%, Tween, 2%,
casein. After a blocking step with PBS, 0.05%, Tween,quently, cells were brought to quiescence by placing
them in DMEM with 0.5% FCS. After 24 hours, cells 2%, casein for 1 hour at 37C, 100L of the preincubated
standard or sample was added onto the plates, and incu-were cultured for 4 days in 0.3 mL medium alone (i.e.,
DMEM containing 5.5 mmol/L d-glucose supplemented bated at 37C for 1 hour. A peroxidase-conjugated sec-
ondary rabbit antigoat IgG (Nordic Immunology) waswith 0.5%FCS, 50g/mL ascorbic acid, and 100g/mL
-aminopropionitrile (both purchased at Sigma Chemi- added, and incubated for 1 hour at 37C. The ELISA
was developed with ABTS/H2O2.cal Co., St. Louis, MO, USA), or medium containing
the following additives: 25 mmol/L d-glucose (Merck,
RNA isolation and semiquantitative RT-PCRDarmstadt, Germany), 25 mmol/L l-glucose (Sigma), or
recombinant human TGF-1 (R&D Systems, Abingdon, Total cellular RNA was extracted using RNAzolB
(Campro Scientific, Veenendaal, The Netherlands) ac-UK). Blocking anti-TGF- studies were performed by
the addition of a neutralizing anti-human TGF-1, 2, 3 cording to manufacturer’s description. The quantity and
purity of the isolated RNA was measured at optical den-monoclonal antibody (mAb) (2G7) [27] or a control
mouse immunoglobulin (IgG) at the start of the culture. sity (OD)260 and OD280 and analyzed on a 0.5 TBE
(0.045 mol/L Tris borate, 0.001 mol/L EDTA) 1% aga-After 4 days, culture supernatants were harvested and
measured for secreted proteins in enzyme-linked immu- rose gel to check the integrity of the RNA.
For reverse transcription-polymerase chain reactionnosorbent assay (ELISA). An aliquot of the supernatants
was measured for total protein content using the BCA (RT-PCR), 1 g total RNA was reverse-transcribed into
cDNA by oligo dT priming using Moloney Murine Leu-protein assay (Pierce Chemical Co., Rockford, IL, USA).
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kemia Virus reverse transcriptase (M-MLV-RT) (all pur- Western blot analysis
chased at Gibco/Life Technologies). The cDNA was am- Growth-arrested TK173 cells were stimulated with re-
plified by PCR using primers for human -actin (forward combinant TGF-1 (1 ng/mL) or with 25 mmol/L d-glucose
primer 5-CTA CAA TGA GCT GCG TGT GG-3, as indicated. Total cellular protein was extracted with
reverse primer 5-AAG GAA GGC TGG AAG AGT a Triton X-100 buffer containing 1% Triton X-100, 20
GC-3, yielding a product of 528 bp), human fibronectin mmol/L Tris pH 7.4, 137 mmol/L NaCl, 10% glycerol, 2
(forward primer 5-CTG GGA TGC TCC TGC TGT mmol/L EDTA, 2 g/mL leupeptin, 2 g/mL antipain,
CAC-3, reverse primer 5-CTG TTT GAT CTG GAC 2 g/mL chymostatin, 5 U/mL trasylol, and 1 mmol/L
CTG CAG-3, yielding a product of 386 bp), and the phenyl methyl sulfonyl fluoride (PMSF). The protein con-
1 subunit of human collagen type III (forward primer tent was determined using the BCA protein assay (Pierce).
Equal amounts of protein were denatured in 3 sodium5-TGA AAG GAC ACA GAG GCT TCG-3, reverse
dodecyl sulfate (SDS) sample buffer (New England Bio-primer 5-GCA CCA TTC TTA CCA GGC TC-3, yield-
labs, Beverly, MA, USA) by boiling and was separateding a product of 532 bp). Each PCR reaction was per-
under reducing conditions by sodium dodecyl sulfate-formed in a total volume of 40 L, containing 10 mmol/L
polyacrylamide gel electrophoresis (SDS-PAGE). TheTrisCl, pH 8.3, 50 mmol/L KCl, 1.5 mmol/L MgCl2, 0.06
proteins were semidry and electroblotted on polyvinyl-mg/mL bovine serum albumin (BSA), 0.25 mmol/L
dene fluoride (PVDF) membranes (Immobilon-p, Milli-dNTPs, 25 pmol forward primer, 25 pmol reverse primer
pore, Bedford, MA, USA). Membranes were blocked with(all primers were purchased at Gibco/Life Technolo-
3% nonfat milk in Tris-buffered saline (TBS), 0.05%gies), and 0.8 U AmpliTaq (Perkin-Elmer, Foster City,
Tween, and then probed with rabbit antiphosphoSmad2CA, USA). Amplification of cDNA started with 5 min-
(a kind gift of Dr. P. ten Dijke, Netherlands Cancer Insti-utes of denaturation at 95C, followed by 35 PCR cycles
tute, Amsterdam, The Netherlands). After incubationof 95C for 1 minute, 60C for 1 minute, and 72C for 1
with a peroxidase-conjugated swine antirabbit Ig (Dako,minute. The final extension was performed at 72C for
Glostrup, Denmark), detection was performed with Su-7 minutes. All PCR reactions were performed in a Gene
persignal (Pierce) and the blots were exposed to Hyper-Amp PCR System 9700 (Perkin-Elmer, Applied Biosys-
film films (Amersham Pharmacia Biotech, Bucking-tems, Foster City, CA, USA) thermal cycler. PCR prod-
hamshire, UK).ucts were analyzed on a 0.5 TBE 1% agarose gel. The
intensity of bands was determined by densitometry, using Generation of stable transfectants with truncated
EagleSight software (Stratagene, La Jolla, CA, USA). TGF- type II receptor
The pGK-mTGF- type II receptor plasmid wasTGF-1 ELISA
kindly provided by Dr. C. Mummery (Hubrecht Labora-TGF-1 secreted in the supernatants was detected us-
tory, Netherlands Institute for Developmental Biology,
ing the DuoSet ELISA development system for human
Utrecht, The Netherlands). It contains a construct encod-
TGF-1 according to manufacturer’s description (R&D ing for a truncated TGF- type II receptor, which lacks
Systems). Measurements of total TGF-1 levels required the entire kinase domain of the receptor [28]. For electro-
prior activation of the samples with acid. poration, 10 g plasmid DNA was added to 6*106 cells
in a single cell suspension of TK173 in 0.6 mL serum-freeTGF-1 bioassay
DMEM in a Gene Pulser cuvette (0.4 cm electrode gap)
Active TGF-1 was measured by the inhibition of (BioRad Laboratories, Hercules, CA, USA). The con-
growth of mink lung cells (MLCCL-64, a gift of Dr. struct was electroporated using a BioRad Gene Pulser
G. van der Pluijm, LUMC, Leiden, The Netherlands). II (260 V, 975 F). Cells were plated in 6-well plates
MLCCL-64 cells were plated at a density of 10,000 cells/ (Greiner), and allowed to recover for 24 hours prior to
well in a 96-well flat-bottom plate (Greiner). Neutraliz- hygromycin B selection (0.1 mg/mL) (Boehringer Mann-
ing pan-specific anti-TGF- antibodies (2G7) or control heim, Germany). Medium was replaced every 3 days.
mouse IgG (both 20 g/mL) were added to test assay Single clones were individually picked and cultured in
specificity. Conditioned media from cell cultures were medium containing hygromycin B.
added, and cultured for 24 hours in a 37C humidified
Statistical analysisincubator with 5% CO2/95% air. 3[H]-Thymidine (Du-
pont, NEN Products, Boston, MA, USA) at 0.5 Ci/well The data are presented as means  SD of triplicate
was added during the final 6 hours of culture. Cells were cultures and are representative for at least three indepen-
lysed and harvested on glass-fiber filters and counted dent experiments. Differences between various culture
for scintillation in a 1205 beta-plate liquid scintillation conditions were evaluated by ANOVA with a Bonfer-
roni correction for multiple comparison, or, when twocounter (both from Walloc, Turku, Finland).
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levels [29]. Exposure of TK173 for 4 days to hyperglyce-
mic conditions (i.e., 25 mmol/L d-glucose, resulted in a
significant mean 1.5-fold increase (N 	 4, range 1.4 to 1.6)
in fibronectin protein compared to normoglycemia (5.5
mmol/L d-glucose) (Fig. 1B). This increase was not due
to the higher osmolarity to which the cells were exposed,
since there was no effect on fibronectin accumulation
when the cells were incubated with 25 mmol/L l-glucose.
Exposure to the profibrotic cytokine TGF-1 (1 ng/mL)
also resulted in a significant 1.7-fold increase in fibronec-
tin secretion (N	 4, range 1.7 to 1.8). Similar stimulatory
effects were found when fibroblasts derived from a fi-
brotic kidney (TK188) were exposed to high glucose or
TGF-1 (data not shown).
To exclude that observed effects were caused by
changes in cell number, proliferation of TK173 fibro-
blasts was analyzed. In contrast to subconfluent cells [30],
quiescent confluent cultures of TK173 cells did not result
in significant changes in cell number after exposure to
high glucose or TGF-1 compared to medium control
(data not shown). In addition, measurements of total
protein content in culture supernatants also did not show
any differences between the various culture conditions
(data not shown).
High ambient glucose and TGF-1 increase
fibronectin mRNA expression
To further investigate the mechanism of fibronectin
Fig. 1. Measurement of fibronectin secretion by TK173 cells upon glu- expression induced by high ambient glucose and exoge-
cose stimulation. Cells were cultured with medium containing 5.5 mmol/L, nous TGF-1, mRNA expression of fibronectin was mea-
25 mmol/L d-glucose, or 25 mmol/L l-glucose, or 1 ng/mL transforming
sured. To quantitate mRNA in the different conditions,growth factor-1 (TGF-1). After 4 days of incubation, culture superna-
tants were harvested, and fibronectin secretion was measured. (A ) Serial a semiquantitative RT-PCR was performed by titration
dilutions of fibronectin were measured in the inhibition enzyme-linked of the cDNA using  actin as a housekeeping gene (Fig.
immunosorbent assay (ELISA) as described in the Methods section
2A). Stimulation with TGF-1 or high glucose for 3and this standard curve was included in each ELISA. The detection
limit of this ELISA is 125 ng/mL. (B ) Measurement of fibronectin days resulted in the up-regulation of fibronectin mRNA
secretion in conditioned culture media of TK173 cells. Results are expression. At day 4, TGF-1-induced fibronectin mRNA
expressed as mean  SD of triplicate cultures and representative of
expression was returned to basal levels while the glucose-four independent experiments. *P
 0.001 compared to medium control.
induced up-regulation was increased (Fig. 2B).
Kinetics of fibronectin secretion
conditions were compared, by a Student t test. In some Analysis of mRNA expression suggested different ki-
experiments, relative differences were tested with a one- netics of fibronectin expression after high glucose com-
sample t test. A value of P 
 0.05 was considered to pared to TGF-1 exposure. Stimulation of TK173 cells
represent a significant difference. with 1 ng/mL TGF-1 resulted in a time-dependent in-
crease in fibronectin accumulation in culture superna-
tants (Fig. 3A). Compared to the medium control, theRESULTS
stimulatory effect was already detectable after 24 hours
Exposure of human renal fibroblasts to high glucose of culture. Maximal stimulation with TGF-1 was found
increases fibronectin secretion after 4 days of culture (Fig. 3B). In contrast, after expo-
Fibronectin secretion by human renal fibroblasts was sure to 25 mmol/L d-glucose, increase in fibronectin se-
measured in culture supernatants via a specific inhibition cretion as compared to medium alone was only detectable
ELISA (Fig. 1A). Although accumulated ECM compo- from day 3 onward (Fig. 3A). Under these conditions, the
nents in supernatants are only part of the total secreted maximal stimulation was found at days 5 to 6 resulting
ECM, measurements in supernatants are reliable and in a mean 1.9-fold increase (N 	 3, range 1.7 to 2.4)
(Fig. 3B). There was no effect of exposure to 25 mmol/Lsensitive and are representative for total changes in ECM
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Fig. 2. Fibronectin mRNA expression by transforming growth factor-1
(TGF-1)- and high glucose-stimulated TK173 cells. TK173 cells were
stimulated with normal medium (Med), 1 ng/mL TGF-1 (T), or 25 mmol/L
d-glucose (25 d). (A ) Semiquantitative analysis of the amount of cDNA
obtained from TK173 cells after 3 days of stimulation using cDNA ti- Fig. 3. Kinetics of fibronectin secretion by TK173 cells. TK173 cells
trations (100-, 1000-, and 10,000-fold dilutions), analyzed for  actin were stimulated with 5.5 mmol/L glucose (medium) (), 1 ng/mL trans-
and fibronectin. (B ) Quantification of the mRNA expression of fibro- forming growth factor-1 (TGF-1) (), 25 mmol/L d-glucose (), or
nectin after 3 and 4 days of stimulation by densitometric analysis of all 25 mmol/L l-glucose (). (A ) Culture supernatants were harvested at
data by calculating mRNA levels of fibronectin relative to those of  different time points as indicated, and stored at –20C until all superna-
actin. Measurements of ratios in normal glucose media without supple- tants were collected for the measurement of fibronectin in a specific
ments were assigned a relative value of 1, representing control values. inhibition enzyme-linked immunosorbent assay (ELISA). Results are
Results are expressed as mean  SEM of three independent experi- expressed as mean SD of triplicate cultures and representative of three
ments. *P 
 0.05 compared to medium control. independent experiments. *P
 0.05 and **P
 0.001 compared to medium
control at the same day. (B ) Fold increase of fibronectin accumulation
compared to the medium control of the same day. Medium control was
assigned a relative value of 1. Results are expressed as mean  SEM of
three independent experiments each performed in triplicate. *P 
 0.05.
l-glucose at any of the time points tested compared with
the medium control. The observed lag period required
for glucose-induced fibronectin secretion suggests that
high ambient glucose might act via the induction of an cells were exposed to 25 mmol/L d-glucose. Next, active
autocrine profibrotic growth factor. TGF-1 was measured in conditioned medium of TK173
cells in a TGF-1 bioassay. Both recombinant TGF-1
High glucose induces secretion of levels of total TGF-1 and TK173-conditioned medium with or without high
glucose showed an inhibition of mink lung cell prolifera-Since exogenous TGF-1 was shown to stimulate fi-
bronectin expression in TK173 cells, and TGF-1 is an tion (Fig. 4B). Although a neutralizing pan-specific anti-
TGF- antibody (2G7) could reverse the growth inhibi-intermediate in glucose-induced matrix production by
mesangial cells [12, 31, 32], TGF-1 secretion by glucose- tion by TGF-1, it did not affect TK173-conditioned
medium (Fig. 4C). Therefore, part of the inhibition ofstimulated fibroblasts was investigated. Culturing fibro-
blasts in medium containing normal glucose concentrations mink lung cell proliferation by TK173-conditioned me-
dium might be caused by a factor different from TGF-.resulted in a time-dependent increase in levels of total
TGF-1 (Fig. 4A). This production was increased when The activation of TGF--dependent signaling was
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Fig. 5. Phosphorylation of Smad2 upon transforming growth factor-1
(TGF-1) and glucose stimulation. TK173 cells were stimulated with
1 ng/mL TGF-1 for 0, 1, or 2 hours, or with 25 mmol/L d-glucose for
48 hours. Cells were harvested and lysed, and equal amounts of total
cellular protein were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) and probed with rabbit-anti-
phophoSmad2.
studied by investigating phosphorylation of Smad2 upon
TGF-1 or high glucose stimulation. Although stimula-
tion with TGF-1 induced phosphorylation of Smad2,
stimulation with glucose did not result in phosphorylated
Smad2 (Fig. 5). These results support the findings in
the TGF- bioassay that active TGF- is absent in high
glucose-conditioned culture medium of fibroblasts.
Glucose-induced fibronectin production is not
inhibited by neutralizing TGF-
Addition of neutralizing pan-specific anti-TGF- anti-
bodies to cultures of TK173 cells completely inhibited
the stimulatory effect of 1 ng/mL TGF-1 on the secre-
tion of fibronectin, while a control antibody had no effect
(Fig. 6, left panel). In contrast, this neutralizing antibody
could not attenuate the stimulatory effect of high ambi-
ent glucose on the secretion of fibronectin by these renal
fibroblasts (Fig. 6, right panel). Comparable results were
obtained when supernatants were analyzed after 7 days
of culture (data not shown).
Combination of glucose and TGF-1 induces higher
secretion of fibronectin compared to single stimuli
When fibroblasts were stimulated with increasing con-
centrations of exogenous TGF-1, there was a dose-
dependent increase in fibronectin accumulation reaching
a plateau at 1 ng/mL TGF-1 (Fig. 7A). However, expo-
sure of fibroblasts to a combination of 1 ng/mL TGF-1
Fig. 4. Measurement of transforming growth factor-1 (TGF-1) lev- and high glucose resulted in a further increase in fibro-els in conditioned media of TK173 cells. TK173 cells were stimulated
nectin as compared to the single stimuli (Fig. 7B). Thesewith 5.5 mmol/L glucose or 25 mmol/L d-glucose. (A ) Culture superna-
tants, medium () and 25 d-glucose (), were harvested at different data suggest that, in hyperglycemic conditions, alterna-
time points as indicated and stored at –20C until all supernatants were tive factors are secreted by renal fibroblasts, which, incollected for the measurement in a TGF-1 enzyme-linked immunosor-
bent assay (ELISA). Results are expressed as mean  SD of triplicate
cultures and representative for three independent experiments. *P 

0.05 and **P 
 0.001 compared to medium control at the same day.
(B ) After 4 days of incubation, culture supernatants were measured for
active TGF-1 levels by inhibition of growth of mink lung cells. Results TGF- antibodies ( ) or control mouse IgG () were used to test TGF-
are expressed in counts per minute (cpm) as mean  SD of triplicate specificity in the mink lung cell bioassay (). Results are expressed as
wells and representative for three independent experiments. **P 
 the percentage inhibition of 3[H]-thymidine incorporation. Data are
0.001 compared to medium control. (C ) Neutralizing pan-specific anti- expressed as mean  SEM of three independent experiments.
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Fig. 6. Blockade of transforming growth factor-1 (TGF-1) using a
neutralizing antibody. TK173 cells were stimulated with 1 ng/mL TGF-1
or 25 mmol/L d-glucose with or without the addition of a neutralizing
pan-specific anti-TGF- monoclonal antibody (mAb) (20 or 50 g/mL)
or a control mouse IgG (20 or 50 g/mL). After 4 days of incubation,
culture supernatants were harvested, and fibronectin was measured using
a specific inhibition enzyme-linked immunosorbent assay (ELISA). Re-
sults are expressed as mean  SD of triplicate cultures and representa-
tive of three independent experiments. *P
 0.001 compared to medium
control. NS 	 not significant.
combination with TGF-1, have additive effects on fi-
bronectin production.
Collagen type III is up-regulated by high glucose but
not by TGF-1 in TK173 cells Fig. 7. Combination of glucose and transforming growth factor-1
(TGF-1) induces higher fibronectin secretion compared to single stim-To investigate other ECM components secreted by
uli. TK173 cells were incubated with (A ) increasing doses of TGF-1
renal fibroblasts, collagen type III was measured. Expo- in the concentrations of 0.16 to 10.0 ng/mL, and with (B) normal medium
or 25 mmol/L d-glucose in combination with or without 1 ng/mL TGF-1.sure to high glucose resulted in a mean 3.5-fold increase
After 4 days, culture supernatants were harvested, and fibronectin was(N	 5, range 2.7 to 4.2) in collagen type III accumulation
measured using a specific inhibition enzyme-linked immunosorbent
by TK173 cells (Fig. 8A), which is compatible with the assay (ELISA). Results are expressed as mean  SD of triplicate cul-
tures and representative of four independent experiments. *P 
 0.01data on fibronectin. Surprisingly, in contrast to fibronec-
and **P 
 0.001 compared to medium control.tin, collagen type III could not be up-regulated by exoge-
nous TGF-1. Furthermore, mRNA expression of the
1 subunit of collagen type III was up-regulated by high
glucose, while TGF-1 had no effect (Fig. 8B). nous wild-type receptor in the transfected cells. Never-
theless, glucose-induced fibronectin production was notFibronectin secretion by fibroblasts expressing a
affected. Selection of a clone (4) with no TGF-1 re-dominant negative TRII
sponse proves that glucose-induced fibronectin (Fig. 9B)
To obtain definitive evidence for the existence of a and collagen type III (Fig. 9C) in renal fibroblasts can
TGF-1-independent mechanism of matrix up-regula- occur independent of TGF-1.
tion by glucose, TK173 cells were transfected with a
dominant negative form of the TGF- type II receptor.
DISCUSSIONThis receptor, which lacks the entire kinase domain, can
still bind TGF-, but cannot propagate the signal. Stable In the present study, we have investigated the effects
transfectants were generated and single clones were ana- of TGF-1 and high ambient glucose on the secretion
lyzed for their TGF-1 and glucose response (Fig. 9A). of fibronectin and collagen type III by human renal fi-
A variable inhibition of TGF-1-induced fibronectin se- broblasts. We have demonstrated that both fibronectin
mRNA and protein expression can be up-regulated bycretion was observed, due to the presence of the endoge-
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Fig. 8. Collagen type III is up-regulated by high glucose, but not by
transforming growth factor-1 (TGF-1) in TK173 cells. TK173 cells
were cultured with medium containing 5.5 mmol/L, 25 mmol/L d-glu-
cose, 25 mmol/L l-glucose, or 1 ng/mL TGF-. (A ) After 4 days of in-
cubation, culture supernatants were harvested, and collagen type III
was measured using a specific inhibition enzyme-linked immunosorbent
assay (ELISA). Results are expressed as mean  SD of triplicate cul-
tures and representative of five independent experiments. *P 
 0.001
compared to medium control. (B ) After 3 days of stimulation, total
RNA was isolated, and a semiquantitative reverse transcripton-poly-
merase chain reaction (RT-PCR) was performed for the 1 subunit of
collagen type III using cDNA titrations (10-, 100-, and 1000-fold dilu-
tions). Densitometric analysis was performed by calculating mRNA Fig. 9. Fibronectin and collagen type III secretion by fibroblasts ex-
levels of 1 (III) relative to those of  actin. Measurements of ratios pressing a dominant negative transforming growth factor- type II re-
in normal glucose media without supplements were assigned a relative ceptor (TRII). TK173 wild-type or dominant negative TRII-express-
value of 1, representing control values. Results are expressed as mean ing cells were stimulated with normal medium, 1 ng/mL transforming
SEM of three independent experiments, **P 
 0.02 compared to me- growth factor-1 (TGF-1), or 25 mmol/L d-glucose. After 7 days, cul-
dium control. ture supernatants were harvested, and fibronectin and collagen type III
were measured using a specific inhibition enzyme-linked immunosor-
bent assay (ELISA). (A ) Fold-increase in fibronectin secretion after
TGF-1 () or 25 mmol/L d-glucose stimulation () of wild-type TK173
cells and five different TK173 single clones (1 to 5) expressing a domi-TGF-1, as well as by high glucose. Glucose-induced nant negative TRII compared to the medium controls. Fibronectin
fibronectin production by renal fibroblasts in vitro can (B ) and collagen type III secretion (C ) in supernatants of a single clone
(4) of TK173 cells expressing a dominant negative TRII. Results areoccur independent of TGF-1, since neutralizing pan-
expressed as mean SD of triplicate cultures and representative of threespecific anti-TGF- antibodies could not attenuate the independent experiments, *P 
 0.001 compared to medium control.
glucose-induced fibronectin accumulation, and fibro-
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blasts expressing a dominant negative TGF- type II ation, as seen previously with the same cells under sub-
confluent conditions [30].receptor were still capable to increase their fibronectin
Although endogenous TGF-1 can be by-passed inproduction upon glucose stimulation. Furthermore, al-
the glucose-induced ECM production in our study, exog-though high glucose increased collagen type III accumu-
enous TGF-1 does have effects on ECM itself. Fibro-lation, it was not up-regulated by TGF-1. These results
nectin mRNA expression was up-regulated by TGF-1indicate a novel mechanism by which hyperglycemic con-
and returned to basal levels after 4 days. This finding isditions might modulate matrix production.
compatible with the fibronectin protein levels that reachPrevious studies by our group and others, especially
a plateau after 4 days of TGF-1 stimulation. This mightin mesangial cells, have clearly demonstrated a link be-
be due to a negative feedback loop to regulate the inten-tween hyperglycemic conditions and an increased matrix
sity or duration of the TGF- signal, like the up-regula-production. In contrast to our present observations, these
tion of Smad7 [35]. Surprisingly, we found no effect ofstudies showed that glucose-mediated effects were de-
TGF-1 on collagen type III protein secretion. This non-pendent on autocrine TGF-1 production [12, 15, 19].
responsiveness was also observed at the transcriptionalHowever, different cell types have distinctive ECM ex-
level, since there was also no effect on the mRNA expres-pression profiles and might also have diverse mecha-
sion of the 1 subunit of collagen type III. This finding isnisms of regulation [11, 12]. We found that renal fibro-
not representative for all collagens, since in preliminaryblasts produced TGF-1 exclusively in its inactive latent
experiments, we have found that TGF-1 was able toform as shown previously by Jones et al [16] in primary
up-regulate collagen type I (data not shown). Although itcultures. Initially, our results seemed conflicting since
has been found in a previous study that glucose-inducedconditioned medium of TK173 cells was able to inhibit
collagen type I is TGF--dependent in murine fibroblaststhe proliferation of mink lung cells, a widely used TGF-
[15], our preliminary data suggest that glucose-inducedbioassay. However, this activity could not be neutralized
collagen type I in human renal fibroblasts can occurby pan-specific anti-TGF- antibodies, suggesting the
independent of TGF-1 (data not shown). These differ-presence of another inhibiting factor. For instance, insu-
ences might be related to the cell origin that might affectlin-like growth factor binding proteins can inhibit mink
the regulatory processes of matrix production.lung cell proliferation via the TGF- type V receptor
Our in vitro studies with isolated renal fibroblasts have[33]. In addition, a lack of Smad2 phosphorylation in
clearly allowed the discovery of a TGF-1-independentglucose-stimulated fibroblasts further support our find-
pathway. Still our finding that high glucose increases theing that active TGF- is absent, since Smad proteins are
production of latent TGF-1 might have important incommon factors in the signaling pathways of members
vivo implications. The paracrine presence of activators
of the TGF- family [34]. There are several additional
of TGF-1, like plasmin [36] and thrombospondin-1
arguments to support our finding that glucose-induced (TSP-1) [37], will lead to TGF-1 activation and subse-
ECM production can occur independent of TGF-1: (1) quent profibrotic actions. In this respect, expression of
glucose-mediated effects are not inhibited by a neutraliz- TSP-1 by tubular epithelial cells [37] might be critical
ing pan-specific anti-TGF- antibody, (2) a combination for the cross talk between different interstitial cells [38].
of glucose and TGF-1 (in optimal concentrations) re- In mesangial cells, TSP-1 expression is critical for auto-
sults in additive effects on fibronectin production, (3) crine TGF-1 activation, and blocking TSP-1 with spe-
collagen type III is up-regulated by high glucose, but not cific peptides completely blocked the glucose-mediated
by TGF-1, and (4) stable transfectants expressing a effects on matrix production [39].
dominant negative TGF- type II receptor, that still can An important question is which alternative factors
bind TGF-1, but cannot propagate the signal [28], show might be responsible for the observed increased ECM
a normal glucose response. expression in renal fibroblasts. Although direct effects
Exposure of renal fibroblasts to high glucose resulted of glucose cannot be excluded, the pronounced delay in
in an increased production of matrix components. We kinetics, both at protein and mRNA levels, does suggest
demonstrate an important impact of glucose on fibro- production of autocrine mediators. In the literature, other
nectin production, an important component of the fi- examples of increased matrix production independent
brotic process in the kidney [23]. However, the effect was of TGF-1 included hypoxia-induced collagen type IV
not exclusive for fibronectin, since similar stimulatory in proximal tubular epithelial cells and renal fibroblasts
effects were found on the secretion of collagen type III. [40, 41], glucose-induced collagens in cortical fibroblasts
Surprisingly, we found no changes in cell proliferation [16], and glucose-induced fibronectin in endothelial cells
and total protein content of TK173 cells upon glucose [42] were also found to be TGF-1-independent pro-
stimulation. This is most likely due to the culture condi- cesses. Furthermore, angiotensin II and insulin-like
tions of confluent layers, since we also did not observe growth factor-1 have been implicated as TGF-1-inde-
pendent inducers of matrix expression [43, 44]. In recentthe stimulatory effects of TGF-1 on TK173 cell prolifer-
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extracellular matrix components in human diabetic glomerular le-years, connective tissue growth factor (CTGF) has re-
sions. Am J Pathol 139:889–899, 1991
ceived much attention as a profibrotic factor (reviewed 8. Steffes MW, Bilous RW, Sutherland DE, et al: Cell and matrix
in [45]). CTGF was identified as a glucose-responsive components of the glomerular mesangium in type I diabetes. Dia-
betes 41:679–684, 1992gene in mesangial cells, and its expression is increased
9. Vleming LJ, Baelde JJ, Westendorp RG, et al: Progression ofin diabetic nephropathy [46]. Although CTGF was char- chronic renal disease in humans is associated with the deposition
acterized as a downstream mediator of TGF-1, expres- of basement membrane components and decorin in the interstitial
extracellular matrix. Clin Nephrol 44:211–219, 1995sion of CTGF independent of TGF-1 has been sug-
10. van Det NF, van den Born J, Tamsma JT, et al: Effects of highgested [47, 48]. Therefore, CTGF might be a potential glucose on the production of heparan sulfate proteoglycan by mes-
candidate to modulate matrix production in human renal angial and epithelial cells. Kidney Int 49:1079–1089, 1996
11. Danne T, Spiro MJ, Spiro RG: Effect of high glucose on type IVfibroblasts under hyperglycemic conditions.
collagen production by cultured glomerular epithelial, endothelial,
and mesangial cells. Diabetes 42:170–177, 1993
12. Wahab NA, Harper K, Mason RM: Expression of extracellularCONCLUSION matrix molecules in human mesangial cells in response to pro-
longed hyperglycaemia. Biochem J 316(Pt 3):985-992, 1996This study demonstrates that in a human renal fibro-
13. Strutz F, Okada H, Lo CW, et al: Identification and characteriza-blast cell line glucose-induced fibronectin and collagen tion of a fibroblast marker: FSP1. J Cell Biol 130:393–405, 1995
type III accumulation can occur independent of TGF-1. 14. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, et al: Myo-
fibroblasts and the progression of diabetic nephropathy. NephrolHowever, the secretion by fibroblasts of latent TGF-1
Dial Transplant 12:43–50, 1997induced by glucose, followed by paracrine activation, can 15. Han DC, Isono M, Hoffman BB, et al: High glucose stimulates
contribute to the important role of TGF-1 in the fibrotic proliferation and collagen type I synthesis in renal cortical fibro-
blasts: Mediation by autocrine activation of TGF-beta. J Am Socprocess in vivo. Nevertheless, next to TGF-1, additional
Nephrol 10:1891–1899, 1999growth factors might be involved in the mechanism by
16. Jones SC, Saunders HJ, Qi W, et al: Intermittent high glucose
which hyperglycemic conditions modulate ECM accu- enhances cell growth and collagen synthesis in cultured human
tubulointerstitial cells. Diabetologia 42:1113–1119, 1999mulation, the hallmark of diabetic nephropathy. Further
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